133.99
price down icon0.96%   -1.3302
 
loading

Illumina Inc Aktie (ILMN) Neueste Nachrichten

pulisher
08:14 AM

Voya Investment Management LLC Has $5.23 Million Stock Holdings in Illumina, Inc. $ILMN - MarketBeat

08:14 AM
pulisher
07:11 AM

United states DNA Forensics Market to Reach USD 5.60 Billion - openPR.com

07:11 AM
pulisher
Dec 25, 2025

Swedbank AB Grows Position in Illumina, Inc. $ILMN - MarketBeat

Dec 25, 2025
pulisher
Dec 24, 2025

Life Science Instruments & Consumables Market to Reach USD - openPR.com

Dec 24, 2025
pulisher
Dec 24, 2025

Genomics in Cancer Care Market to Reach USD 72.87 Billion by 2033 | - openPR.com

Dec 24, 2025
pulisher
Dec 24, 2025

Illumina Inc. Stock Underperforms Tuesday When Compared To Competitors - 富途牛牛

Dec 24, 2025
pulisher
Dec 24, 2025

Genomics Market Outlook: Market to Reach US$ 118.2 Billion - openPR.com

Dec 24, 2025
pulisher
Dec 23, 2025

Illumina Inc ILU Stock Analysis and ForecastTechnical Breakout Signals & Fast Growing Capital Growth - earlytimes.in

Dec 23, 2025
pulisher
Dec 23, 2025

Illumina Inc. stock underperforms Tuesday when compared to competitors - MarketWatch

Dec 23, 2025
pulisher
Dec 23, 2025

Is Illumina Inc Gaining or Losing Market Support? - Sahm

Dec 23, 2025
pulisher
Dec 23, 2025

Illumina, Inc. $ILMN Stock Holdings Lessened by Assenagon Asset Management S.A. - MarketBeat

Dec 23, 2025
pulisher
Dec 22, 2025

Canaccord Genuity Maintains Illumina (ILMN) Hold Recommendation - Nasdaq

Dec 22, 2025
pulisher
Dec 22, 2025

Illumina Inc. stock outperforms competitors on strong trading day - MarketWatch

Dec 22, 2025
pulisher
Dec 22, 2025

Illumina (NASDAQ:ILMN) Price Target Raised to $130.00 - MarketBeat

Dec 22, 2025
pulisher
Dec 22, 2025

Illumina (ILMN) Surges 3.3%: Is This an Indication of Further Gains? - Yahoo Finance

Dec 22, 2025
pulisher
Dec 22, 2025

Illumina Inc. Stock Outperforms Competitors On Strong Trading Day - 富途牛牛

Dec 22, 2025
pulisher
Dec 21, 2025

Douglas Lane & Associates LLC Acquires 18,914 Shares of Illumina, Inc. $ILMN - MarketBeat

Dec 21, 2025
pulisher
Dec 20, 2025

Why Illumina Inc. (ILU) stock could rally stronglySwing Trade & Stepwise Trade Signal Guides - Улправда

Dec 20, 2025
pulisher
Dec 20, 2025

Illumina (ILMN): Evaluating the Stock’s Valuation After Its Strategic AI-Genomics Partnership With MyOme - Yahoo Finance

Dec 20, 2025
pulisher
Dec 19, 2025

Why hedge funds are buying Illumina Inc. stockJuly 2025 Rallies & Risk Controlled Stock Alerts - Улправда

Dec 19, 2025
pulisher
Dec 19, 2025

Can Illumina Inc. stock deliver consistent earnings growthJuly 2025 Sector Moves & Weekly Chart Analysis and Guides - Улправда

Dec 19, 2025
pulisher
Dec 19, 2025

Is Illumina Inc. stock a smart buy before Fed meetingJuly 2025 Retail & Fast Gain Stock Trading Tips - DonanımHaber

Dec 19, 2025
pulisher
Dec 19, 2025

Why Illumina Inc. (ILU) stock stays on buy listsStop Loss & AI Powered Buy and Sell Recommendations - DonanımHaber

Dec 19, 2025
pulisher
Dec 19, 2025

Is Illumina Inc. stock undervalued vs historical averages2025 Year in Review & Smart Money Movement Alerts - ulpravda.ru

Dec 19, 2025
pulisher
Dec 19, 2025

Will Illumina Inc. stock outperform international peersWeekly Investment Report & Expert Verified Movement Alerts - ulpravda.ru

Dec 19, 2025
pulisher
Dec 18, 2025

Is Illumina Inc. stock supported by innovation pipelineWeekly Trading Summary & Real-Time Price Movement Reports - Улправда

Dec 18, 2025
pulisher
Dec 18, 2025

“It can’t wait until tomorrow”: How patient advocacy drives change - Illumina

Dec 18, 2025
pulisher
Dec 18, 2025

DNA/Gene Microarray Market Growth Potential Examined Through - openPR.com

Dec 18, 2025
pulisher
Dec 18, 2025

Illumina, Inc. $ILMN Shares Acquired by Aaron Wealth Advisors LLC - MarketBeat

Dec 18, 2025
pulisher
Dec 18, 2025

Illumina Inc (NASDAQ:ILMN) Nasdaq Futures Shape Discovery Market Now - Kalkine Media

Dec 18, 2025
pulisher
Dec 18, 2025

Discipline and Rules-Based Execution in ILMN Response - news.stocktradersdaily.com

Dec 18, 2025
pulisher
Dec 17, 2025

Illumina Inc. stock underperforms Wednesday when compared to competitors - MarketWatch

Dec 17, 2025
pulisher
Dec 17, 2025

Illumina Target of Unusually Large Options Trading (NASDAQ:ILMN) - MarketBeat

Dec 17, 2025
pulisher
Dec 17, 2025

How AstraZeneca improved their genomics processing to be 60% faster, 70% more cost-effective - Amazon Web Services (AWS)

Dec 17, 2025
pulisher
Dec 17, 2025

Sicart Associates LLC Has $7.89 Million Stock Position in Illumina, Inc. $ILMN - MarketBeat

Dec 17, 2025
pulisher
Dec 16, 2025

Scott Davies Sells 323 Shares of Illumina (NASDAQ:ILMN) Stock - MarketBeat

Dec 16, 2025
pulisher
Dec 16, 2025

How to watch Illumina's J.P. Morgan healthcare conference webcast - Stock Titan

Dec 16, 2025
pulisher
Dec 16, 2025

Meet three scientists behind Illumina’s spatial assay breakthrough - Illumina

Dec 16, 2025
pulisher
Dec 16, 2025

Santa Rally Looms: These 5 Stocks Often Deliver Gifts To Investors - Benzinga

Dec 16, 2025
pulisher
Dec 16, 2025

Gene Prediction Tool Industry Report 2025: Precision Genomics, - openPR.com

Dec 16, 2025
pulisher
Dec 16, 2025

Barclays Maintains Illumina (ILMN) Underweight Recommendation - Nasdaq

Dec 16, 2025
pulisher
Dec 15, 2025

JP Morgan Maintains Illumina (ILMN) Neutral Recommendation - Nasdaq

Dec 15, 2025
pulisher
Dec 15, 2025

Illumina (NASDAQ:ILMN) Given New $130.00 Price Target at JPMorgan Chase & Co. - MarketBeat

Dec 15, 2025
pulisher
Dec 15, 2025

Twists, tangles, and transcription: Does epigenetics play a role in Alzheimer's? - Illumina

Dec 15, 2025
pulisher
Dec 15, 2025

Thrivent Financial for Lutherans Purchases 684,802 Shares of Illumina, Inc. $ILMN - MarketBeat

Dec 15, 2025
pulisher
Dec 15, 2025

United States DNA Sequencing Market 2031 | Growth Drivers, Key - openPR.com

Dec 15, 2025
pulisher
Dec 15, 2025

Illumina, Inc. $ILMN Shares Bought by Neuberger Berman Group LLC - MarketBeat

Dec 15, 2025
pulisher
Dec 15, 2025

Marex Group plc Makes New $1.24 Million Investment in Illumina, Inc. $ILMN - MarketBeat

Dec 15, 2025
pulisher
Dec 15, 2025

NGS Based RNA Sequencing Market is growing at a CAGR of 19.7%, - openPR.com

Dec 15, 2025
pulisher
Dec 14, 2025

Illumina and MyOme Strike Collaboration Deal Including Strategic Investment to Support MyOme's Clinical Trial That Could Save U.S. Healthcare $200 Billion Annually - PR Newswire

Dec 14, 2025
pulisher
Dec 14, 2025

Illumina’s AI Genomics Partnership With MyOme Might Change The Case For Investing In Illumina (ILMN) - Sahm

Dec 14, 2025
pulisher
Dec 14, 2025

Nikko Asset Management Americas Inc. Increases Stake in Illumina, Inc. $ILMN - MarketBeat

Dec 14, 2025
pulisher
Dec 13, 2025

AQR Capital Management LLC Raises Stock Holdings in Illumina, Inc. $ILMN - MarketBeat

Dec 13, 2025
pulisher
Dec 13, 2025

4D Advisors LLC Purchases Shares of 30,000 Illumina, Inc. $ILMN - MarketBeat

Dec 13, 2025
pulisher
Dec 12, 2025

Illumina Inc. Stock Underperforms Friday When Compared To Competitors - 富途牛牛

Dec 12, 2025
pulisher
Dec 12, 2025

Illumina Inc. stock underperforms Friday when compared to competitors - MarketWatch

Dec 12, 2025
pulisher
Dec 12, 2025

Officer Davies Files To Sell 323 Of Illumina Inc [ILMN] - TradingView — Track All Markets

Dec 12, 2025
pulisher
Dec 12, 2025

Using genomic testing to deliver hope to families - Illumina

Dec 12, 2025
pulisher
Dec 12, 2025

DNA Computing Market - GlobeNewswire Inc.

Dec 12, 2025
pulisher
Dec 12, 2025

Why Illumina (ILMN) is a Top Momentum Stock for the Long-Term - Yahoo Finance

Dec 12, 2025
pulisher
Dec 12, 2025

Maple Rock Capital Partners Inc. Sells 26,145 Shares of Illumina, Inc. $ILMN - MarketBeat

Dec 12, 2025
pulisher
Dec 12, 2025

Ilex Capital Partners UK LLP Raises Stock Position in Illumina, Inc. $ILMN - MarketBeat

Dec 12, 2025
pulisher
Dec 12, 2025

Ieq Capital LLC Buys 176,611 Shares of Illumina, Inc. $ILMN - MarketBeat

Dec 12, 2025
pulisher
Dec 12, 2025

Illumina, Inc. $ILMN Shares Purchased by Cerity Partners LLC - MarketBeat

Dec 12, 2025
pulisher
Dec 11, 2025

Your lab’s new best friend for scalable proteomics: Illumina Protein Prep - Illumina

Dec 11, 2025
diagnostics_research LH
$253.38
price down icon 0.35%
diagnostics_research WAT
$385.93
price up icon 0.28%
diagnostics_research MTD
$1,415.97
price down icon 0.10%
$234.05
price down icon 0.69%
diagnostics_research IQV
$226.48
price down icon 0.00%
Kapitalisierung:     |  Volumen (24h):